Match each patient presentation of suspected stable ischemic heart disease with the most appropriate guideline-indicated next step in diagnostic test sequencing.
- A 48-year-old patient with intermittent atypical chest pain, an interpretable resting electrocardiogram, and unrestricted physical mobility.Exercise electrocardiography (without imaging)
- A 64-year-old patient evaluating for exertional angina who can exercise vigorously, but has a resting electrocardiogram demonstrating left ventricular hypertrophy with 1.5 mm ST-segment depressions.Exercise stress imaging (echocardiography or myocardial perfusion)
- A 72-year-old patient with typical angina who cannot use a treadmill due to advanced osteoarthritis, and has poorly controlled asthma with active baseline wheezing.Pharmacologic stress testing with dobutamine echocardiography
- A 67-year-old patient with typical angina who is physically active and capable of exercise, but has a baseline electrocardiogram showing a left bundle branch block.Pharmacologic stress testing with vasodilator myocardial perfusion imaging
Cevap
The normal baseline ECG capable of exercise pairs with exercise electrocardiography. The ST-depressions capable of exercise pairs with exercise stress imaging. The patient with asthma unable to exercise pairs with dobutamine echocardiography. The patient with a left bundle branch block pairs with vasodilator myocardial perfusion imaging.
Appropriate test sequencing in stable ischemic heart disease requires triaging based on exercise capacity, ECG interpretability, and specific pharmacologic contraindications. The correct pairings align physical capacity with exercise stressors, uninterpretable ECGs with imaging, asthma with dobutamine, and LBBB with vasodilators.
Adım Adım Çözüm
Anahtar Kavram
The selection of the initial noninvasive diagnostic test for suspected stable ischemic heart disease depends on evaluating the patient's ability to exercise, the interpretability of their baseline electrocardiogram, and the presence of comorbidities that contraindicate specific pharmacologic stress agents.